TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection
Background: Head and neck squamous cell carcinoma is a heterogeneous disease with respect to the anatomic site of the primary tumor. On the other hand, it is highly recurrent, and once metastatic, it is associated with poor prognosis. TP53 is the most commonly mutated gene in primary disease. TP53 m...
Main Authors: | Apostolos Klinakis, Theodoros Rampias |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-08-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396420302802 |
Similar Items
-
A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma
by: Congyu Shi, et al.
Published: (2021-09-01) -
Analysis of mutation and promoter methylation of TP53 gene in tumors of the head and neck
by: Jarzynski Adrian, et al.
Published: (2016-06-01) -
Integrative Analysis of TP53INP2 in Head and Neck Squamous Cell Carcinoma
by: Ruoyan Cao, et al.
Published: (2021-04-01) -
<em>TP53</em> as clinical marker in head and neck cancer
by: Peltonen, J. (Jenni)
Published: (2011) -
Deciphering the Increased Prevalence of TP53 Mutations in Metastatic Prostate Cancer
by: Dong, Y., et al.
Published: (2022)